What are Pathways?
Pathways are a quality improvement tool for the Ontario cancer system. They are flowcharts that show a high-level overview of the care a cancer patient in Ontario should receive. Pathways focus on one type of cancer, during a specific phase of the cancer journey, with the understanding that the patient journey differs from one cancer to another.
Click here to learn more about disease pathway maps - Healthcare Provider Q&A
The following pathways have been developed by Cancer Care Ontario to guide cancer treatment in the province:
- Lung - Small cell lung cancer
- Lung- Non-small cell lung cancer
- Colorectal - Colon and rectal cancer
- Prostate
- Breast
- Bladder
- Cervical
- Ovarian
- Psychosocial Oncology and Palliative Care
- Thyroid
What are Guidelines?
Cancer Care Ontario's Program in Evidence-Based Care (PEBC) produces evidence-based guidance documents in partnership with clinical experts in all major cancer disease sites and across all clinical programs and modalities. Below are a list of PEBC guidelines:
- Breast
- Gastrointestinal (anal, colorectal, pancreatic, esophageal, gastric)
- Genitourinary (prostate, kidney, testis)
- Gynecologic (vulva, ovary, endometrium, cervix)
- Head and neck
- Hematology
- Lung (small cell, non-small cell, mesothelioma, thymoma)
- Melanoma
- Neuro-oncology
- Sarcoma
Click here to view pathways related to the diagnostic phase.
Immune Checkpoint Inhibitor Side Effect Toolkit
The Immune Checkpoint Inhibitor Toxicity Management Toolkit has been designed to help support individuals taking immune checkpoint inhibitor medications. These individuals may experience side effects that require urgent treatment, and this toolkit will help providers determine the best course of action.
Oncological Emergencies
- Anaphylaxis
- Cytokine Release Syndrome
- Spinal Cord Compression
- Superior Vena Cava Obstruction
- Tumour Lysis Syndrome
Reference:
Cancer Care Ontario